Sign In
Buy PACB
$1.45
-0.180 (-11.04%)
At Close: Jun 05, 2026
Pacific Biosciences of California, Inc. (PACB) CEO Christian Henry on Q1 2022 Results - Earnings Call Transcript
02:09am, Thursday, 05'th May 2022
Pacific Biosciences of California, Inc. (NASDAQ:PACB ) Q1 2022 Earnings Conference Call May 4, 2022 5:00 PM ET Company Participants Todd Friedman - Director, IR Christian Henry - President and Chief E
Pacific Biosciences of California (PACB) Reports Q1 Loss, Tops Revenue Estimates
10:05pm, Wednesday, 04'th May 2022 Zacks Investment Research
Pacific Biosciences (PACB) delivered earnings and revenue surprises of -15.63% and 1.29%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Pacific Biosciences of California (PACB) Reports Q1 Loss, Tops Revenue Estimates
07:33pm, Wednesday, 04'th May 2022
Pacific Biosciences (PACB) delivered earnings and revenue surprises of -15.63% and 1.29%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
2 Reasons to Buy Illumina, and 1 Reason to Sell
12:50pm, Thursday, 28'th Apr 2022 The Motley Fool
Shares are near a 52-week low, but is that cheap enough?
Pacific Biosciences of California (PACB) Expected to Beat Earnings Estimates: Should You Buy?
07:03pm, Wednesday, 27'th Apr 2022 Zacks Investment Research
Pacific Biosciences (PACB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Pacific Biosciences of California (PACB) Expected to Beat Earnings Estimates: Should You Buy?
04:49pm, Wednesday, 27'th Apr 2022
Pacific Biosciences (PACB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PacBio and Children’s Mercy Kansas City Expand Collaboration Taking a Multi-Omics Approach to Characterize Rare Disease
01:10pm, Thursday, 21'st Apr 2022 GlobeNewswire Inc.
MENLO PARK, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing solutions, today announced an expanded research collabor
PacBio to Report First Quarter 2022 Financial Results on May 4, 2022
08:02pm, Wednesday, 20'th Apr 2022 GlobeNewswire Inc.
MENLO PARK, Calif., April 20, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its first quarter 2022 financial results on We
Lessons For Elon Musk: 5 Notorious Failed Hostile Takeovers
01:59pm, Friday, 15'th Apr 2022 Benzinga
As any student of industry knows, Elon Musk is hardly the first person to attempt a hostile takeover. But while the Tesla (NASDAQ: TSLA) chieftain’s $54.20 per share bid for Twitter (NYSE: TWTR) con
3 Things About Pacific Biosciences of California That Smart Investors Know
12:25pm, Tuesday, 12'th Apr 2022 The Motley Fool
Anyone thinking about buying shares should know them, too.
Pacific Biosciences Hit By Sentiment, But The Future Of Long-Read Sequencing Is Strong
12:32pm, Tuesday, 05'th Apr 2022
PacBio shares have been hit hard as investors have abandoned riskier high-multiple life sciences stocks, and weaker guidance for FY'22 certainly didn't help.
HiFi Reads Enable Telomere-to-Telomere Consortium to Fill the Final Gaps in the Human Genome, Heralding a New Era of Research into Genetic Diseases and Human Biology
06:00pm, Thursday, 31'st Mar 2022 GlobeNewswire Inc.
Science magazine publication details how the human genome was finally completed with the help of PacBio long-read technology Science magazine publication details how the human genome was finally compl
PacBio Opens European Headquarters in London
01:00pm, Wednesday, 23'rd Mar 2022 GlobeNewswire Inc.
Company Announces New European Headquarters to Serve Growing Customer Demand in Europe, Middle East and Africa Region
LHC Group (LHCG) Ties Up to Improve Home Health Services
03:00pm, Friday, 18'th Mar 2022 Zacks Investment Research
LHC Group's (LHCG) latest joint venture with Archbold Medical Center to enhance home health services in Thomasville and across South Georgia.
Illumina (ILMN) Invests in Seven Additional Genomics Startups
02:08pm, Friday, 18'th Mar 2022 Zacks Investment Research
Illumina's (ILMN) investment in seven new genomics companies is intended to advance breakthrough therapeutics, diagnostics, DNA storage, mental wellness and sustainable foods applications.
